SCHEMBL6817751

SCHEMBL6817751

C(#CC1CCC2CCN1CC2)c1ccno1

nearest known ligand 0.33

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
CHRNA7 P36544 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6817171 0.90 CHRNB2 (0.32) CHRNA7
SCHEMBL6820640 0.85
SCHEMBL6816895 0.84
SCHEMBL6817810 0.77 TOP1 (0.30)
SCHEMBL6919182 0.76 CHRNA7 (0.33) CHRNA7
SCHEMBL6813247 0.72 CHRM2 (0.31) CHRNA7
SCHEMBL6817097 0.71 CHRNB2 (0.39) CHRNA7
SCHEMBL6816338 0.70 CHRM2 (0.30)
SCHEMBL6817792 0.70 CHRNA7 (0.32) CHRNA7
SCHEMBL6817247 0.70 CHRNA4 (0.32) CHRNA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004009599-A1 FIVE-MEMBERED HETEROAROMATIC OLEFINIC AZACYCLIC COMPOUNDS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USE AS INHIBITORS OF NCOTINIC CHOLINERGIC RECEPTORS TARGACEPT, INC. (US) 2004-01-29 WO claimed
WO-2004009599-A1 FIVE-MEMBERED HETEROAROMATIC OLEFINIC AZACYCLIC COMPOUNDS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USE AS INHIBITORS OF NCOTINIC CHOLINERGIC RECEPTORS TARGACEPT, INC. (US) 2004-01-29 WO disclosed